India Pharma Outlook Team | Friday, 28 November 2025
Lupin Human Welfare and Research Foundation (LHWRF), the CSR wing of global pharmaceutical leader Lupin Limited, has earned the top-tier CRISIL Voluntary Organisation rating of VO 1A—a distinction that signifies exceptional program delivery capability and strong financial management.This achievement underscores LHWRF’s long-standing commitment to accountability, quality, and measurable social impact.
For more than 37 years, the Foundation has led efforts to enhance healthcare access, boost livelihoods, and support community development in underserved regions across India. Its mission remains centered on empowering people and fostering sustainable, holistic progress.
Also Read: Piramal Pharma Marks Major Milestone in Nitrosamine Compliance“We are proud to receive the VO 1A rating from CRISIL, which highlights our dedication to social development and inclusive growth,” said Tushara Shankar, Head of CSR at Lupin. “This recognition motivates us to further scale our innovative community initiatives and deepen our positive impact.”The CRISIL VO grading system provides an in-depth evaluation of an organisation’s ability to meet its objectives.
It examines key areas such as stakeholder involvement, operational processes, implementation and monitoring rigor, and financial stewardship—covering aspects like cost control, revenue management, resource diversification, cash flow, and transparency in reporting.